As large insurers, such as United Healthcare, Humana and Aetna, drop out of the Healthcare.gov marketplace, consumers are left with fewer and fewer choices, especially in certain geographic areas.
Sarah Kliff, Sarah Frostenson and Soo Oh of Vox gathered the data to show us just how little competition there will be:
“There are currently 687 counties on the Healthcare.gov marketplace with just one insurer signed up to sell in 2017 — nearly four times the 182 counties that had one insurer this year.”
A study presented this summer at an international dental conference has added to growing evidence that topical applications of silver diamine fluoride can serve as an effective treatment for tooth decay.
The paper, presented at the meeting of the International Association of Dental Research in South Korea, concluded that annual application the compound stopped the progress of root decay among community-dwelling elders living in Hong Kong. Continue reading
Podcasts are all the rage, so we’ve been collecting some health policy-related ones for you. Some of these regularly tackle health policy, some dip into it once in a while (but smartly) and others are geared more toward science and medicine.
Some of you who contributed suggestions noted that a few popular general podcasts (such as On Media and Fresh Air) aren’t health-focused but sometimes have good episodes, respectively, on media coverage and interviews with authors of health books. Continue reading
Mylan’s price hike for its EpiPen allergy medication fueled an Internet storm this week, with consumers and U.S. legislators expressing outrage over its decision to raise the price about 400% since 2007 to as much as $500 or more. The backlash appeared tied in part to timing as U.S. children head back to school, with parents of those needing EpiPens to treat allergic reactions coming to grips with the hefty price tag.
The incident brought echoes of another drug price hike – the 2015 increase by Turing Pharmaceutical’s malaria and HIV medicine Darapim, another move that brought scrutiny by the House Oversight and Government Reform Committee of the company’s chief executive officer. Continue reading
Why are the nuances of Medicare benefits so complicated? While journalists may never find the answer to this question, they can be more aware of this challenge as they shape their reporting.
Medicare’s arcane and overlapping regulations mean consumers often lose or are penalized for benefits for which they are entitled, according to journalist Philip Moeller, who writes about aging and related issues for PBS NewsHour and Money. Continue reading